Hinova Pharmaceuticals (SHSE:688302) Common Stock : ¥99.02 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Hinova Pharmaceuticals Common Stock?

Hinova Pharmaceuticals's quarterly common stock stayed the same from Mar. 2024 (¥99.02 Mil) to Jun. 2024 (¥99.02 Mil) and stayed the same from Jun. 2024 (¥99.02 Mil) to Sep. 2024 (¥99.02 Mil).

Hinova Pharmaceuticals's annual common stock increased from Dec. 2021 (¥74.26 Mil) to Dec. 2022 (¥99.02 Mil) but then stayed the same from Dec. 2022 (¥99.02 Mil) to Dec. 2023 (¥99.02 Mil).

Hinova Pharmaceuticals Common Stock Historical Data

The historical data trend for Hinova Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hinova Pharmaceuticals Common Stock Chart

Hinova Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

29.58

74.26

99.02

Hinova Pharmaceuticals Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial														99.02	99.02	99.02	99.02	99.02

Hinova Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Hinova Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hinova Pharmaceuticals Inc (SHSE:688302) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041

Website

http://www.hinovapharma.com

Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

Hinova Pharmaceuticals Headlines

No Headlines